LobbyingBright Path Laboratories lobbying by quarter
Bright Path Laboratories's latest lobbying report covers Q2 2026, at $60K. Its first report covers Q1 2026; the issues it reports most are Medical/Disease Research/Clinical Labs.
Bright Path Laboratories
- Latest quarter
- $60K
- Q2 2026 · 1 reports
- Last 12 months
- $120K
- Last 2 quarters
- vs last quarter
- 0.0%
- Q2 2026 against the quarter before
- First report
- Q1 2026
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q1 2026 | $60K | 1 |
| Q2 2026 | $60K | 1 |
Policy issues the reports name
- Medical research and clinical labs2 reports
A report that names several issues counts once for each.
Who was lobbied
- Commerce, Dept of (DOC)2 reports
- HOUSE OF REPRESENTATIVES2 reports
- Office of Management & Budget (OMB)2 reports
- SENATE2 reports
Firms it paid
| Firm | ||
|---|---|---|
| The Conafay Group | $120K | 2 quarters |
Former officials lobbying for it
| Former position | ||
|---|---|---|
| BRYAN SHUY | Chief of Staff Rep. Harris; Asst. to Rep. Harris, House Cmte on Approps; Dep. Asst. Sec and Chief ofStaff HHS/Asst.Secretary for Preparedness and Response(ASPR) | Q2 2026 |
| JOSH NARROW | Intern to Senator Casey | Q2 2026 |
Lobbying reports
| Filed by | ||
|---|---|---|
| 07/20for Q2 | The Conafay Group | $60K |
| 04/20for Q1 | The Conafay Group | $60K |
| 02/27for Q1 | The Conafay Group | Under $5,000 |